Suppr超能文献

替代决策者的准确性:一项系统综述。

The accuracy of surrogate decision makers: a systematic review.

作者信息

Shalowitz David I, Garrett-Mayer Elizabeth, Wendler David

机构信息

Department of Clinical Bioethics, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Arch Intern Med. 2006 Mar 13;166(5):493-7. doi: 10.1001/archinte.166.5.493.

Abstract

BACKGROUND

Clinicians currently rely on patient-designated and next-of-kin surrogates to make end-of-life treatment decisions for incapacitated patients. Surrogates are instructed to use the substituted judgment standard, which directs them to make the treatment decision that the patient would have made if he or she were capacitated. However, commentators have questioned the accuracy with which surrogates predict patients' treatment preferences.

METHODS

A systematic literature search was conducted using PubMed, the Cochrane Library, and manuscript references, to identify published studies that provide empirical data on how accurately surrogates predict patients' treatment preferences and on the efficacy of commonly proposed methods to improve surrogate accuracy. Two of us (D.I.S. and D.W.) reviewed all articles and extracted data on the hypothetical scenarios used to assess surrogate accuracy and the percentage of agreement between patients and surrogates.

RESULTS

The search identified 16 eligible studies, involving 151 hypothetical scenarios and 2595 surrogate-patient pairs, which collectively analyzed 19 526 patient-surrogate paired responses. Overall, surrogates predicted patients' treatment preferences with 68% accuracy. Neither patient designation of surrogates nor prior discussion of patients' treatment preferences improved surrogates' predictive accuracy.

CONCLUSIONS

Patient-designated and next-of-kin surrogates incorrectly predict patients' end-of-life treatment preferences in one third of cases. These data undermine the claim that reliance on surrogates is justified by their ability to predict incapacitated patients' treatment preferences. Future studies should assess whether other mechanisms might predict patients' end-of-life treatment preferences more accurately. Also, they should assess whether reliance on patient-designated and next-of-kin surrogates offers patients and/or their families benefits that are independent of the accuracy of surrogates' decisions.

摘要

背景

临床医生目前依靠患者指定的代理人及近亲作为代理人,为无行为能力的患者做出临终治疗决策。代理人被指示采用替代判断标准,即指导他们做出患者在有行为能力时会做出的治疗决策。然而,评论者质疑代理人预测患者治疗偏好的准确性。

方法

使用PubMed、Cochrane图书馆及手稿参考文献进行系统的文献检索,以识别已发表的研究,这些研究提供了关于代理人预测患者治疗偏好的准确程度以及常用的提高代理人预测准确性方法的有效性的实证数据。我们两人(D.I.S.和D.W.)审查了所有文章,并提取了用于评估代理人预测准确性的假设情景以及患者与代理人之间的一致百分比的数据。

结果

检索确定了16项符合条件的研究,涉及151个假设情景和2595对代理人 - 患者,共分析了19526对患者 - 代理人配对反应。总体而言,代理人预测患者治疗偏好的准确率为68%。患者指定代理人以及事先讨论患者的治疗偏好均未提高代理人的预测准确性。

结论

患者指定的代理人及近亲代理人在三分之一的情况下错误地预测了患者的临终治疗偏好。这些数据削弱了以下观点,即依靠代理人能够预测无行为能力患者的治疗偏好,因此这种做法是合理的。未来的研究应评估其他机制是否能更准确地预测患者的临终治疗偏好。此外,还应评估依靠患者指定的代理人及近亲代理人是否能为患者和/或其家人带来独立于代理人决策准确性之外的益处。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验